Skip to main content
letter
. 2020 Aug 22;31(11):1582–1584. doi: 10.1016/j.annonc.2020.08.2096

Figure 1.

Figure 1

R1b-S116 haplotype frequency versus COVID-19 prevalence (30 April 2020) in the Netherlands and Flanders (A) [log (prevalence) = 2.8684 + 7.543 X (R1b-S116 haplotype frequency), r2 = 0.601] and in a group of 28 countries (B) [log (prevalence) = 2.848 + 5.561 X (R1b-S116 haplotype frequency), r2 = 0.390].